HRMY
Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.02
−1.68%Forward multiples
Based on analyst estimates
- P/E forward
- 10.49x
- P/E 2026E
- 10.70x
- P/E 2027E
- 9.86x
- P/E 2028E
- 8.73x
- P/S forward
- 2.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- 13.42x
- PEG TTM
- 0.48x
- Price / book
- 2.45x
- Price / sales
- 2.55x
- Price / cash flow
- 6.89x
Enterprise value
- Enterprise value
- $1.9B
- EV / sales
- 2.01x
- EV / EBITDA
- 6.99x
- EV / EBIT
- 8.38x
- Market cap
- $2.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026